Aspen Neuroscience
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10835 Road To the Cure Ste 100, San Dieg...Phone Number
(858) 263-1222Website
www.aspenneuroscience.comRevenue
$31.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About Aspen Neuroscience
Headquartered in San Diego, Aspen Neuroscience, Inc. is a development stage, private biotechnology company focused on personalized (autologous) cell therapies. The company is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.Explore more
Aspen Neuroscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aspen Neuroscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aspen Neuroscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Aspen Neuroscience has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Aspen Neuroscience
Product Launch: Get notified when Aspen Neuroscience launches new products
Check out if Aspen Neuroscience is spiking on competitors!
Earning: See what the market has to say on Aspen Neuroscience recently announced quarterly report
Click to see if Aspen Neuroscience had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aspen Neuroscience has new funding data
Recommended Actions
Reach out to Masked Content who joined Aspen Neuroscience as Masked Content
Find more new buyers
Compare Similar Companies to Aspen Neuroscience
Compare insights from companies similar to Aspen Neuroscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aspen Neuroscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aspen Neuroscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aspen Neuroscience.
Aspen Neuroscience financials insights
Gather financial insights about Aspen Neuroscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$6.5M
2020
Series A
$70M
2022
Series B
$147.5M
Debt
$40M
2025
Series C
$115M
Aspen Neuroscience Tech Stack
A closer look at the technologies used by Aspen Neuroscience
Most Recent Scoops
Person-Based
Manufacturing Operations
Hiring Plans
Aspen Neuroscience has more open roles in Operations than it has had at any time in the past 12 months with an increased focus that include Manufacturing Operations, and experience with Cycle Counting, E-Kanban, Equipment Maintenance, Organizing Meetings, Smart Labels, and Materials Management.
Hiring Plans
New Hire
Executive Move
Executive Moves, New Hire
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Aspen Neuroscience News & Media
Aspen Neuroscience Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel (ANPD001) to Treat Parkinson's Disease
SAN DIEGO, July 30, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous cell therapies, today announced that sasineprocel (ANPD001), its lead investigational product, for the treatment of...Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson's Disease
Advancement of commercial-ready formulation supports scalability and late-stage development SAN DIEGO, June 30, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous cell therapies, today announced...Aspen Neuroscience Appoints Jeff Boerneke as General Counsel and Secretary
Experienced biotech legal executive strengthens leadership team as Aspen advances clinical development and prepares for Phase 3 growth SAN DIEGO, June 11, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized,...Aspen Neuroscience Announces Positive 12‑Month Data from its ASPIRO Clinical Trial in a Late‑Breaking Oral Presentation at the AD/PD™ 2026 International Conference on Alzheimer's and Parkinson's Diseases
Results Show Continued Safety, Tolerability, and Sustained Clinical Benefit Including Improvements in Function, Physician- and Patient-Reported Outcomes, and Quality-of-Life This Personalized Autologous Cell Therapy Aims to Replace and Restore the Damaged Neural Circuitry in Parkinson's...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Aspen Neuroscience
Sign Up For FreeTo access detailed company insights
Headquartered in San Diego, Aspen Neuroscience, Inc. is a development stage, private biotechnology company focused on personalized (autologous) cell therapies. The company is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic... Read More
